HealthPolitics

STAT+: Psilocybin’s lasting benefits prove elusive in mice

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 02/11/2026, 21:06:24 UTC.

Briefings

An eight-month investigation by STAT revealed that clinics and intermediaries market mitochondrial replacement therapy as a 'three-parent IVF' service to older women seeking genetically related children. The study found scant evidence supporting these destination IVF businesses, which charge tens of thousands of dollars for procedures with no scientific backing. The article notes that while the FDA accepted an AMT-130 gene therapy application for Huntington's disease, the specific approval date is May 1, 2027, and the FDA is tentatively planning an advisory committee meeting to review this data.

Key points

• STAT conducted an eight-month investigation into clinics marketing mitochondrial replacement therapy as 'three-parent IVF' to older women.
• The investigation found scant evidence for destination IVF businesses, which charge tens of thousands of dollars for procedures with no scientific backing.

Context

The article discusses a biotech news story involving AMT-130 gene therapy for Huntington's disease, noting the FDA accepted the marketing application but the specific approval date is May 1, 2027. It also covers a separate medical tourism trend where clinics market mitochondrial replacement therapy to older women for genetically related children.

Limitations

The evidence is limited to an eight-month investigation by STAT, which found scant evidence for destination IVF businesses. The article does not provide specific numbers or dates for the medical tourism business, nor does it offer causal claims about the effectiveness of the treatments or the specific financial costs beyond 'tens of thousands of dollars'. The source explicitly states the article is a 'full story' continuation, implying the investigation details are part of a larger narrative.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 03/11/2026, 00:59:01 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeidswwxsz3q5vf3ybt6l7krhfmz2be7u6tl7k6jgi7pfqv5dsuk7l4